MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Young Onset Parkinson’s Disease (YOPD): A different disease entity?

H. Chan, Y. Cheung, D. Chau, V. Lo, C. Woo, S. Tse, T. Fung, A. Leung, W. Fong (Hong Kong, Hong Kong)

Meeting: 2017 International Congress

Abstract Number: 1103

Keywords: Parkinsonism

Session Information

Date: Wednesday, June 7, 2017

Session Title: Phenomenology and Clinical Assessment Of Movement Disorders

Session Time: 1:15pm-2:45pm

Location: Exhibit Hall C

Objective: To study the clinical manifestations of YOPD and Late Onset Parkinson’s Disease (LOPD) patients

Background: Parkinson’s disease (PD) is a neurodegenerative disease commonly affecting the elderly population. However, there is a group of PD patients who develop the illness much earlier and is known as YOPD. Unfortunately, literature studying this group of patients is scarce.

Methods: Study design: Cross-sectional study

Inclusion criteria: All PD patients who were followed in the multidisciplinary PD clinic of Queen Elizabeth Hospital, Hong Kong

YOPD is defined as those with age of onset ≤ 50 years old while LOPD is defined as those with age of onset > 50 years old.

Method:

1. The demographic information was documented.

2. Their motor function was assessed by a.  Modified Hoehn and Yahr (H & Y) Stage; b. Unified Parkinson’s Disease Rating Scale (UPDRS) part III and total score; c.  Presence of early morning dystonia.

3. Their non-motor function was evaluated by Non Motor Symptom Scale (NMSS).

4. SPSS version 20 was used for statistical analysis.

5. Chi square and t tests were used to test for differences.

Results: 182 patients were recruited between 2014 and 2016.

The YOPD group had 53 patients, whereas the LOPD group had 129 patients.

Baseline characteristics: There was no significant difference between the two groups in terms of gender, PD subtype and family history. However, as compared with the LOPD group, the YOPD group was found to be younger (54.45 ± 7.77 years in the YOPD group vs. 68.01 ± 7.30 years in the LOPD group, P < 0.00) and have a longer disease duration (10.53 ± 6.32 years in the YOPD group vs. 6.34 ± 4.27 years in the LOPD group, P < 0.00).

Motor function: There was no significant difference between the two groups in terms of motor function except the presence of early morning dystonia (P = 0.05) (Table 1).

Non motor function: In general, there was no significant difference in the NMSS total score between the two groups. Nevertheless, the YOPD group was reported to have more mood and cognitive problems (P = 0.03), while the LOPD group tended to have more urinary dysfunction (P = 0.05) (Table 2).

Conclusions: In conclusion, there was no significant difference in the motor and non-motor function between the YOPD and LOPD groups.

To cite this abstract in AMA style:

H. Chan, Y. Cheung, D. Chau, V. Lo, C. Woo, S. Tse, T. Fung, A. Leung, W. Fong. Young Onset Parkinson’s Disease (YOPD): A different disease entity? [abstract]. Mov Disord. 2017; 32 (suppl 2). https://www.mdsabstracts.org/abstract/young-onset-parkinsons-disease-yopd-a-different-disease-entity/. Accessed July 12, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/young-onset-parkinsons-disease-yopd-a-different-disease-entity/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Screening and Treatment of Depression in Parkinson’s Disease within Movement Disorders Centers: A Quality Improvement Initiative
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • Effect of marijuana on Essential Tremor: A case report
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • Patients with Essential Tremor Live Longer than their Relatives
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley